PapersFlow Research Brief
Thyroid Disorders and Treatments
Research Guide
What is Thyroid Disorders and Treatments?
Thyroid disorders and treatments encompass a range of conditions involving abnormal thyroid hormone production, including hypothyroidism, hyperthyroidism, and thyroid nodules, managed through diagnostic testing, hormone replacement, antithyroid drugs, and specialized guidelines for pregnancy and postpartum care.
The field includes 115,779 published works on thyroid disorders and treatments. Population studies such as the National Health and Nutrition Examination Survey (NHANES III) measured serum TSH, T4, and thyroid antibodies in 17,353 U.S. individuals aged 12 and older, establishing reference data for thyroid function. Community surveys like the Whickham Survey reported overt hyperthyroidism prevalence at 19/1000 females and hypothyroidism at 16/1000 females.
Research Sub-Topics
Thyroid Hormone Receptor Signaling
This sub-topic investigates the molecular mechanisms of thyroid hormone receptors, their co-regulators, and gene transcription pathways. Researchers study ligand binding, nuclear translocation, and therapeutic targeting in disorders.
Subclinical Hypothyroidism Epidemiology
This sub-topic analyzes population prevalence, risk factors, and natural history of subclinical hypothyroidism using surveys like NHANES. Researchers assess progression to overt disease and cardiovascular associations.
Thyroid Disease in Pregnancy
This sub-topic covers maternal thyroid function impacts on fetal neurodevelopment, guidelines for levothyroxine use, and postpartum monitoring. Researchers conduct RCTs and cohort studies on outcomes like IQ deficits.
Hyperthyroidism Management Guidelines
This sub-topic evaluates antithyroid drugs, radioiodine therapy, and surgery for Graves' disease and toxic nodules per ATA guidelines. Researchers compare remission rates, side effects, and long-term relapse.
Thyroid Dysfunction Cardiovascular Effects
This sub-topic examines thyroid hormone influences on cardiac contractility, vascular function, and arrhythmia risks. Researchers link TSH levels to heart failure and atherosclerosis in population studies.
Why It Matters
Thyroid disorders impact cardiovascular health, as Klein and Ojamaa (2001) detailed in "Thyroid Hormone and the Cardiovascular System," where thyroid hormone alters heart hemodynamics, with hyperthyroidism increasing cardiac output and hypothyroidism causing opposite effects. In pregnancy, untreated maternal hypothyroidism associates with child neuropsychological deficits, as Haddow et al. (1999) found in "Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the Child." The Colorado Thyroid Disease Prevalence Study by Canaris et al. (2000) showed only 60% of medicated patients had normal TSH levels, with modest TSH elevations linking to adverse lipid changes. Guidelines from the American Thyroid Association, such as Ross et al. (2016) providing 124 recommendations for hyperthyroidism management, guide clinical practice. Recent developments include FDA priority review for veligrotug, an anti-IGF-1R antibody for thyroid eye disease.
Reading Guide
Where to Start
"Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)" by Hollowell et al. (2002), as it provides foundational reference data from a large U.S. population sample of 17,353 individuals on TSH, T4, and thyroid antibodies.
Key Papers Explained
Hollowell et al. (2002) "Serum TSH, T<sub>4</sub>, and Thyroid Antibodies..." establishes U.S. population references, which Canaris et al. (2000) "The Colorado Thyroid Disease Prevalence Study" builds on by showing 60% normal TSH in medicated patients and lipid associations. Tunbridge et al. (1977) "THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY" reports community prevalence (19/1000 hyperthyroidism in females), extended by Vanderpump et al. (1995) "The incidence of thyroid disorders..." with 20-year follow-up incidence. Ross et al. (2016) "2016 American Thyroid Association Guidelines..." synthesizes these into 124 hyperthyroidism management recommendations.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints highlight links between hypothyroidism and chronic kidney disease, clinical challenges in differentiated thyroid cancer management via ultrasonography, and knowledge gaps in hypothyroidism diagnosis. News focuses on veligrotug's FDA priority review and breakthrough designation for thyroid eye disease by Viridian Therapeutics.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The Steroid and Thyroid Hormone Receptor Superfamily | 1988 | Science | 7.6K | ✓ |
| 2 | Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United... | 2002 | The Journal of Clinica... | 3.8K | ✕ |
| 3 | Guidelines of the American Thyroid Association for the Diagnos... | 2011 | Thyroid | 2.9K | ✕ |
| 4 | The Colorado Thyroid Disease Prevalence Study | 2000 | Archives of Internal M... | 2.8K | ✕ |
| 5 | 2016 American Thyroid Association Guidelines for Diagnosis and... | 2016 | Thyroid | 2.7K | ✓ |
| 6 | THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM S... | 1977 | Clinical Endocrinology | 2.7K | ✕ |
| 7 | 2017 Guidelines of the American Thyroid Association for the Di... | 2017 | Thyroid | 2.6K | ✓ |
| 8 | Maternal Thyroid Deficiency during Pregnancy and Subsequent Ne... | 1999 | New England Journal of... | 2.6K | ✓ |
| 9 | The incidence of thyroid disorders in the community: a twenty‐... | 1995 | Clinical Endocrinology | 2.4K | ✕ |
| 10 | Thyroid Hormone and the Cardiovascular System | 2001 | New England Journal of... | 2.3K | ✕ |
In the News
News Details
Veligrotug is an intravenously delivered, anti-insulin-like growth factor-1 receptor (IGF-1R) antibody in phase 3 development for thyroid eye disease, with the potential to be the IV treatment-of-c...
Veligrotug Receives FDA Priority Review for Thyroid Eye ...
The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for veligrotug for the treatment of thyroid eye disease (TED).
Thyroid eye disease treatment granted priority review
The FDA granted priority review to veligrotug for the treatment of thyroid eye disease, according to a press release from Viridian Therapeutics.
Viridian Therapeutics: FDA Breakthrough for Veligrotug in TED
_\- Breakthrough Therapy Designation request based on veligrotug’s (i) consistent and robust improvement and resolution of diplopia in chronic TED, and (ii) rapid onset of proptosis response -_
Viridian Therapeutics submits Biologics License ...
5. ###### Viridian Therapeutics receives FDA breakthrough therapy designation for veligrotug for the treatment of thyroid eye disease (TED). News release. Viridian Therapeutics, Inc. May 7, 2025. A...
Code & Tools
| Thyroid Nodules | EndoGPT: A Proof-of-concept Large Language Model Based Assistant for the Management of Thyroid Nodules | medRxiv 2024 | GPT-4o ...
ACR Assist is a clinical decision support framework designed to provide structured clinical guidance to radiologists in a manner that allows this c...
The Thyroid Disease Prediction project is designed to predict the presence of thyroid diseases using machine learning models. The project leverages...
Thyroid Disease Detection Thyroid disease is a very common problem in India, more than one crore people are suffering with the disease every year. ...
The most common thyroid disorder is hypothyroidism. Hypo- means deficient or under(active), so hypothyroidism is a condition in which the thyroid g...
Recent Preprints
Thyroid diseases - Latest research and news
There is a substantial link between thyroid disease, particularly hypothyroidism, and renal dysfunction, including chronic kidney disease (CKD). This Review explores the epidemiology and the molecu...
Clinical Advances in Thyroid Disease Assessment and Management
Thyroid disorders affect millions worldwide, with differentiated thyroid cancer (DTC) representing the most common endocrine malignancy. Detection rates have risen substantially, largely due to the...
Natural product-based interventions for thyroid disorders
Thyroid diseases are widespread endocrine disorders that affect a significant portion of the global population. The pathology associated with specific types or stages of thyroid disease is complex ...
Thyroid Hormones in Brain Development and Function - NCBI
developed from rodent studies, with a focus on the human brain.
Knowledge gaps about the diagnosis and treatment of ...
**Introduction:** Over-diagnosis and over-treatment of hypothyroidism is a growing concern. The role of patient knowledge has not been previously investigated. The aim was to explore patient knowle...
Latest Developments
Recent developments in thyroid disorders and treatments research include the establishment of new clinical guidelines for differentiated thyroid cancer management by the ATA in 2025 (discovery.researcher.life) and the FDA breakthrough therapy designation granted in 2025 for Veligrotug for thyroid eye disease (investors.viridiantherapeutics.com). Additionally, research continues into natural and lifestyle approaches to thyroid health, such as iodine, selenium, stress management, and diet modifications (parsleyhealth.com), and studies explore the role of vitamin D and reverse T3 in thyroid function (onlinelibrary.wiley.com, nesaz.com).
Sources
Frequently Asked Questions
What prevalence of thyroid dysfunction exists in the U.S. population?
NHANES III by Hollowell et al. (2002) measured serum TSH, total T4, TPOAb, and TgAb in 17,353 people aged 12 and older, providing reference data for thyroid function across geographic and ethnic groups. The Colorado Thyroid Disease Prevalence Study by Canaris et al. (2000) confirmed substantial abnormal biochemical thyroid function, with only 60% of thyroid-medicated patients within normal TSH range.
How are thyroid diseases managed during pregnancy?
Stagnaro-Green et al. (2011) in "Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum" developed evidence-based recommendations for individualized care in pregnant and postpartum women. Alexander et al. (2017) updated these in "2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum," incorporating advances since 2011.
What is the community prevalence of thyroid disorders?
The Whickham Survey by Tunbridge et al. (1977) in "THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY" examined 2,779 adults, finding overt hyperthyroidism at 19/1000 females and hypothyroidism at 16/1000 females. Vanderpump et al. (1995) followed up over 20 years in "The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey," documenting incidence rates.
What guidelines exist for hyperthyroidism?
Ross et al. (2016) in "2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis" provided 124 evidence-based recommendations for thyrotoxicosis care. These outline rational medical practice for patients with hyperthyroidism.
How do thyroid hormones affect the cardiovascular system?
Klein and Ojamaa (2001) in "Thyroid Hormone and the Cardiovascular System" explained that thyroid hormone alters cardiovascular hemodynamics, with hyperthyroidism increasing cardiac output and hypothyroidism producing opposite effects. Clinical manifestations of thyroid disorders often stem from these hemodynamic changes.
What role do steroid receptors play in thyroid function?
Evans (1988) in "The Steroid and Thyroid Hormone Receptor Superfamily" identified a superfamily of regulatory proteins, providing molecular insights into transcriptional control and cell identity influenced by thyroid hormone receptors.
Open Research Questions
- ? What molecular mechanisms link thyroid dysfunction to chronic kidney disease, as suggested by recent reviews?
- ? How can over-diagnosis and over-treatment of hypothyroidism be reduced through improved patient knowledge?
- ? What are the long-term outcomes of veligrotug treatment in active and chronic thyroid eye disease patients?
- ? How do natural product interventions affect specific pathways in thyroid disorders?
- ? What gaps remain in understanding thyroid hormone roles in human brain development beyond rodent models?
Recent Trends
Preprints from the last six months discuss hypothyroidism's link to renal dysfunction including CKD, rising detection of differentiated thyroid cancer due to ultrasonography, and concerns over over-diagnosis of hypothyroidism.
News from the last 12 months reports FDA priority review and breakthrough therapy designation for veligrotug by Viridian Therapeutics for thyroid eye disease, with phase 3 development targeting diplopia and proptosis.
Research Thyroid Disorders and Treatments with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Thyroid Disorders and Treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.